Oncology Historical Balance Sheet

TOI Stock

USD 1.26 0.02 1.61%

Trend analysis of Oncology Institute balance sheet accounts such as Total Stockholder Equity of 78.4 M, Other Liab of 6.7 M, Net Tangible Assets of 101.2 M or Property Plant And Equipment Net of 48.4 M provides information on Oncology Institute's total assets, liabilities, and equity, which is the actual value of Oncology Institute to its prevalent stockholders. By breaking down trends over time using Oncology Institute balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Oncology Institute latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Oncology Institute is a good buy for the upcoming year.

Oncology Institute Inventory

8.28 Million

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Oncology Institute. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.

About Oncology Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Oncology Institute at a specified time, usually calculated after every quarter, six months, or one year. Oncology Institute Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Oncology Institute and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Oncology currently owns. An asset can also be divided into two categories, current and non-current.

Oncology Institute Balance Sheet Chart

As of now, Oncology Institute's Net Debt is increasing as compared to previous years. The Oncology Institute's current Other Current Assets is estimated to increase to about 5.7 M, while Common Stock Shares Outstanding is projected to decrease to under 70.4 M.

Common Stock Shares Outstanding Total Assets Other Current Liab Total Current Liabilities

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of Oncology Institute assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Oncology Institute books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Oncology Institute balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Oncology Institute are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Oncology Institute's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Oncology Institute current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Oncology Institute. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.As of now, Oncology Institute's Net Debt is increasing as compared to previous years. The Oncology Institute's current Other Current Assets is estimated to increase to about 5.7 M, while Common Stock Shares Outstanding is projected to decrease to under 70.4 M.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	13.3M	13.5M	15.5M	11.2M
Total Assets	263.7M	209.2M	240.6M	176.4M

Other Current Liab Total Assets

Oncology Institute balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets
Common Stock Shares Outstanding		0.86	0.87	0.88	0.68	0.3	0.72	0.77	0.5	-0.82	0.73	0.56	0.72	0.8	0.84	0.81	0.81	-0.01	0.84	0.76	0.72	0.89	0.86	0.81	0.75	0.84
Total Assets	0.86		0.98	0.89	0.85	0.39	0.88	0.84	0.51	-0.84	0.73	0.65	0.86	0.91	0.97	0.95	0.92	0.07	0.97	0.87	0.82	0.96	0.97	0.98	0.82	0.97
Other Current Liab	0.87	0.98		0.94	0.78	0.44	0.9	0.84	0.47	-0.89	0.84	0.72	0.76	0.95	0.97	0.98	0.92	-0.01	0.98	0.9	0.83	0.99	0.98	0.95	0.83	1.0
Total Current Liabilities	0.88	0.89	0.94		0.59	0.32	0.76	0.83	0.52	-0.94	0.91	0.62	0.65	0.92	0.91	0.88	0.89	-0.15	0.92	0.89	0.73	0.98	0.94	0.82	0.83	0.92
Total Stockholder Equity	0.68	0.85	0.78	0.59		0.55	0.84	0.55	0.22	-0.49	0.42	0.65	0.84	0.58	0.72	0.8	0.6	0.48	0.71	0.49	0.87	0.71	0.7	0.84	0.51	0.78
Other Liab	0.3	0.39	0.44	0.32	0.55		0.72	-0.03	-0.56	-0.19	0.51	0.92	0.05	0.24	0.26	0.62	0.06	0.61	0.27	0.1	0.81	0.37	0.28	0.3	-0.04	0.51
Net Tangible Assets	0.72	0.88	0.9	0.76	0.84	0.72		0.66	0.16	-0.73	0.77	0.9	0.6	0.78	0.8	0.97	0.69	0.19	0.82	0.68	0.94	0.84	0.82	0.84	0.64	0.93
Property Plant And Equipment Net	0.77	0.84	0.84	0.83	0.55	-0.03	0.66		0.84	-0.92	0.66	0.34	0.75	0.88	0.87	0.74	0.92	-0.45	0.89	0.9	0.5	0.85	0.89	0.84	1.0	0.81
Net Debt	0.5	0.51	0.47	0.52	0.22	-0.56	0.16	0.84		-0.64	0.24	-0.22	0.66	0.6	0.59	0.28	0.74	-0.62	0.61	0.68	0.0	0.51	0.6	0.56	0.84	0.4
Retained Earnings	-0.82	-0.84	-0.89	-0.94	-0.49	-0.19	-0.73	-0.92	-0.64		-0.87	-0.55	-0.58	-0.93	-0.87	-0.83	-0.89	0.4	-0.9	-0.91	-0.62	-0.92	-0.92	-0.79	-0.93	-0.87
Accounts Payable	0.73	0.73	0.84	0.91	0.42	0.51	0.77	0.66	0.24	-0.87		0.78	0.32	0.83	0.75	0.85	0.71	-0.19	0.77	0.78	0.72	0.86	0.8	0.63	0.68	0.85
Cash	0.56	0.65	0.72	0.62	0.65	0.92	0.9	0.34	-0.22	-0.55	0.78		0.25	0.56	0.56	0.85	0.4	0.33	0.57	0.44	0.92	0.67	0.59	0.56	0.34	0.77
Non Current Assets Total	0.72	0.86	0.76	0.65	0.84	0.05	0.6	0.75	0.66	-0.58	0.32	0.25		0.67	0.81	0.66	0.8	0.15	0.8	0.66	0.58	0.75	0.78	0.89	0.7	0.72
Non Currrent Assets Other	0.8	0.91	0.95	0.92	0.58	0.24	0.78	0.88	0.6	-0.93	0.83	0.56	0.67		0.97	0.89	0.97	-0.26	0.98	0.99	0.63	0.95	0.98	0.9	0.88	0.94
Other Assets	0.84	0.97	0.97	0.91	0.72	0.26	0.8	0.87	0.59	-0.87	0.75	0.56	0.81	0.97		0.91	0.98	-0.08	1.0	0.95	0.7	0.97	0.99	0.97	0.85	0.96
Cash And Short Term Investments	0.81	0.95	0.98	0.88	0.8	0.62	0.97	0.74	0.28	-0.83	0.85	0.85	0.66	0.89	0.91		0.82	0.11	0.92	0.82	0.91	0.94	0.92	0.9	0.72	0.99
Net Receivables	0.81	0.92	0.92	0.89	0.6	0.06	0.69	0.92	0.74	-0.89	0.71	0.4	0.8	0.97	0.98	0.82		-0.27	0.98	0.98	0.55	0.93	0.97	0.93	0.91	0.89
Good Will	-0.01	0.07	-0.01	-0.15	0.48	0.61	0.19	-0.45	-0.62	0.4	-0.19	0.33	0.15	-0.26	-0.08	0.11	-0.27		-0.12	-0.36	0.43	-0.06	-0.13	0.05	-0.49	0.02
Non Current Liabilities Total	0.84	0.97	0.98	0.92	0.71	0.27	0.82	0.89	0.61	-0.9	0.77	0.57	0.8	0.98	1.0	0.92	0.98	-0.12		0.96	0.71	0.97	1.0	0.97	0.88	0.96
Inventory	0.76	0.87	0.9	0.89	0.49	0.1	0.68	0.9	0.68	-0.91	0.78	0.44	0.66	0.99	0.95	0.82	0.98	-0.36	0.96		0.52	0.91	0.96	0.87	0.9	0.88
Other Current Assets	0.72	0.82	0.83	0.73	0.87	0.81	0.94	0.5	0.0	-0.62	0.72	0.92	0.58	0.63	0.7	0.91	0.55	0.43	0.71	0.52		0.79	0.72	0.74	0.47	0.86
Other Stockholder Equity	0.89	0.96	0.99	0.98	0.71	0.37	0.84	0.85	0.51	-0.92	0.86	0.67	0.75	0.95	0.97	0.94	0.93	-0.06	0.97	0.91	0.79		0.98	0.92	0.84	0.97
Total Liab	0.86	0.97	0.98	0.94	0.7	0.28	0.82	0.89	0.6	-0.92	0.8	0.59	0.78	0.98	0.99	0.92	0.97	-0.13	1.0	0.96	0.72	0.98		0.95	0.88	0.97
Net Invested Capital	0.81	0.98	0.95	0.82	0.84	0.3	0.84	0.84	0.56	-0.79	0.63	0.56	0.89	0.9	0.97	0.9	0.93	0.05	0.97	0.87	0.74	0.92	0.95		0.81	0.94
Property Plant And Equipment Gross	0.75	0.82	0.83	0.83	0.51	-0.04	0.64	1.0	0.84	-0.93	0.68	0.34	0.7	0.88	0.85	0.72	0.91	-0.49	0.88	0.9	0.47	0.84	0.88	0.81		0.79
Total Current Assets	0.84	0.97	1.0	0.92	0.78	0.51	0.93	0.81	0.4	-0.87	0.85	0.77	0.72	0.94	0.96	0.99	0.89	0.02	0.96	0.88	0.86	0.97	0.97	0.94	0.79

Click cells to compare fundamentals

Oncology Institute Account Relationship Matchups

Oncology Institute balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	59.1M	66.2M	80.6M	73.7M	75.0M	70.4M
Total Assets	65.7M	203.4M	263.7M	209.2M	240.6M	176.4M
Other Current Liab	6.1M	13.3M	13.3M	13.5M	15.5M	11.2M
Total Current Liabilities	28.6M	29.8M	29.9M	34.8M	40.0M	30.1M
Total Stockholder Equity	28.1M	104.2M	124.7M	57.0M	65.6M	78.4M
Property Plant And Equipment Net	2.1M	4.2M	33.0M	40.1M	46.1M	48.4M
Net Debt	5.9M	(114.1M)	94.2M	86.2M	99.1M	104.1M
Retained Earnings	(52.3M)	(63.2M)	(61.6M)	(146.2M)	(131.5M)	(125.0M)
Accounts Payable	12.6M	15.6M	9.4M	14.4M	16.6M	13.4M
Cash	6.0M	114.3M	14.0M	33.5M	38.5M	37.5M
Non Current Assets Total	36.0M	49.4M	133.2M	65.7M	75.6M	70.9M
Non Currrent Assets Other	122.5K	320K	369K	561K	645.2K	323.5K
Cash And Short Term Investments	6.0M	114.3M	73.8M	82.9M	95.3M	61.5M
Net Receivables	17.3M	21.2M	40.4M	42.9M	49.3M	30.0M
Good Will	14.2M	26.6M	23.4M	7.2M	6.5M	6.2M
Liabilities And Stockholders Equity	65.7M	203.4M	263.7M	209.2M	240.6M	176.4M
Non Current Liabilities Total	9.0M	69.5M	109.2M	117.4M	135.0M	67.9M
Inventory	4.4M	6.4M	9.3M	13.7M	15.7M	8.3M
Other Current Assets	2.1M	12.1M	6.9M	4.0M	4.7M	5.7M
Other Stockholder Equity	80.4M	167.4M	186.3M	203.2M	233.6M	140.2M
Total Liab	37.6M	99.3M	139.1M	152.2M	175.0M	98.0M
Net Invested Capital	(40.1M)	104.3M	203.8M	143.9M	165.4M	89.3M
Property Plant And Equipment Gross	3.3M	4.2M	33.0M	46.2M	53.2M	55.8M
Total Current Assets	29.7M	154.1M	130.5M	143.5M	165.0M	105.5M
Non Current Liabilities Other	806.2K	25.1M	868K	365K	328.5K	312.1K
Net Working Capital	1.1M	124.3M	100.7M	108.7M	125.0M	75.5M
Intangible Assets	19.5M	18.2M	18.0M	17.9M	16.1M	15.3M

Currently Active Assets on Macroaxis

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria
HMY	Harmony Gold Mining
FSM	Fortuna Silver Mines

When determining whether Oncology Institute offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oncology Institute's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oncology Institute Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oncology Institute Stock:

How To Invest In Oncology

Details

Is Oncology Stock a good investment?

Details

What is Oncology Institute's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.

You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oncology Institute. If investors know Oncology will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oncology Institute listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.71)

Revenue Per Share

5.078

Quarterly Revenue Growth

0.218

Return On Assets

(0.20)

Return On Equity

(1.61)

The market value of Oncology Institute is measured differently than its book value, which is the value of Oncology that is recorded on the company's balance sheet. Investors also form their own opinion of Oncology Institute's value that differs from its market value or its book value, called intrinsic value, which is Oncology Institute's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oncology Institute's market value can be influenced by many factors that don't directly affect Oncology Institute's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Oncology Institute's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncology Institute is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncology Institute's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Oncology Historical Balance Sheet

Oncology Institute Inventory

8.28 Million

About Oncology Balance Sheet Analysis

Oncology Institute Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

Total Current Liabilities

Oncology Institute balance sheet Correlations

Oncology Institute Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Oncology Institute balance sheet Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Other Current Liab
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Non Current Liabilities Total	+ 1.0	Other Assets
Total Liab	+ 1.0	Non Current Liabilities Total
Other Stockholder Equity	+ 0.99	Other Current Liab
Inventory	+ 0.99	Non Currrent Assets Other

Retained Earnings	- 0.94	Total Current Liabilities
Property Plant And Equipment Gross	- 0.93	Retained Earnings
Non Currrent Assets Other	- 0.93	Retained Earnings
Total Liab	- 0.92	Retained Earnings
Other Stockholder Equity	- 0.92	Retained Earnings
Retained Earnings	- 0.92	Property Plant And Equipment Net